Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States
(NOT-GM-21-018)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institute of Nursing Research
Office of Disease Prevention
Office of Research on Women's Health
Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace
(NOT-MH-21-125)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Increase Participant Diversity, Inclusion and Engagement in Clinical Studies
(NOT-NS-21-025)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows
(NOT-OD-21-070)
National Institutes of Health
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
Office of Dietary Supplements
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Office of Research on Women's Health
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
(PAR-21-130)
National Institute of Mental Health
Application Receipt Date(s):
June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022,
February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)
(PAR-21-131)
National Institute of Mental Health
Application Receipt Date(s):
June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
(PAR-21-132)
National Institute of Mental Health
Application Receipt Date(s):
June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022,
February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)
(PAR-21-133)
National Institute of Mental Health
Application Receipt Date(s):
June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
(PAR-21-134)
National Institute of Mental Health
Application Receipt Date(s):
June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022,
February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
(PAR-21-135)
National Institute of Mental Health
Application Receipt Date(s):
June 15, 2021, October 15, 2021February 15, 2022,June 15, 2022, October 14, 2022,
February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024, June 15, 2021, October 15, 2021, February 15, 2022, June 15, 2022, October 14, 2022, February 15, 2023, June 15, 2023, October 17, 2023, February 15, 2024
Firearm Injury and Mortality Prevention Research (R21/R33 Clinical Trial Optional)
(PAR-21-191)
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
Office of Disease Prevention
Office of Research on Women's Health
Application Receipt Date(s):
April 30, 2021, All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Firearm Injury and Mortality Prevention Research (R01Clinical Trial Optional)
(PAR-21-192)
Office of Behavioral and Social Sciences Research
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Disease Prevention
Office of Research on Women's Health
Application Receipt Date(s):
April 30, 2021, All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)
(PAR-21-193)
National Institute for Occupational Safety and Health
Application Receipt Date(s):
Standard dates apply;
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Data Standards for Tobacco Research and Scientific Review Program (U24) Clinical Trial Not Allowed
(RFA-FD-22-002)
Food and Drug Administration
Application Receipt Date(s):
June 1, 2021, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.